PUBLIC CONTRACT · 2025
Ex/464/2025 - Teclistamab 90MG/ml-inj 1,7ML, talquetamab 2MG/ml inj 1,5ML sc e talquetamab 40 mg/ml inj 1ML sc
- Contract value
- €2,366,163.52
- Signed on
- 24 January 2025
- Procedure
- Contratação excluída II
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11322526PUBLISHED SUBJECT
EX/464/2025 - TECLISTAMAB 90MG/ML-INJ 1,7ML, TALQUETAMAB 2MG/ML INJ 1,5ML SC E TALQUETAMAB 40 MG/ML INJ 1ML SC
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412
Values and timeline
- Contract price
- €2,366,163.52
- Procedure base price
- €2,366,163.52
- Total effective price
- Not reported on Portal BASE
- Publication date
- 2 April 2025
- Award date
- 24 January 2025
- Signing date
- 24 January 2025
- Performance period
- 341 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Contratação excluída II
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- artigo 5.º n.º 1 do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7545495
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.